Activity value 62united states Supplier,Last transaction date:
2024-10-23Address: united states,miami,1000 5th st miami florida 33139
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for qalys pharma llc from 2023 to 2024.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2024, the company has completed 43 transactions, with a transaction quantity of 22145.67 and a transaction weight of 4531.37.
YearTransactionsQuantityWeight
20232833157.555708.35
20244322145.674531.37
Bill of lading data
<
1/15
>
Trade date
2024/10/23
B/L No.
——
Suppliers
qalys pharma llc
Buyers
global therapeutics llc
POLs
——
PODs
——
Supply area
United States
Purchas area
Colombia
Weight
0.13kg
Amount
——
Hs code
3003200000
Product tags
medicaments consisting of other antibiotics
Product description
CONTAINING OTHER ANTIBIOTICS
Expand
Trade date
2024/10/23
B/L No.
——
Suppliers
qalys pharma llc
Buyers
global therapeutics llc
POLs
——
PODs
——
Supply area
United States
Purchas area
Colombia
Weight
0.13kg
Amount
468.83
Hs code
3003200000
Product tags
medicaments consisting of other antibiotics
Product description
CONTAINING OTHER ANTIBIOTICS
Expand
Trade date
2024/10/23
B/L No.
——
Suppliers
qalys pharma llc
Buyers
global therapeutics llc
medicaments consisting of other antibiotics 2534.25%>
immunological products 1926.03%>
antisera 1216.44%>
blood fractions 68.22%>
equipped with fixed dose drug 56.85%>
+View All
Hscode rank
Total 10
HSCode NameTransactionsPerDetail
HS 30032000002534.25%>
HS 30021510001926.03%>
HS 300212190068.22%>
HS 300212210068.22%>
HS 901890909056.85%>
+View All
Trading Area
Total 1
AreaTransactionsPerDetail
colombia23100%>
qalys pharma llc is united states Supplier,
and primarily engages in the import and export business of products such as medicaments consisting of other antibiotics,immunological products,antisera.
According to the 52wmb.com global trade database, as of 2024-10-23, the company has completed 77 international trades,
with its main trading regions covering colombia etc.
The core products include HS3003200000,HS3002151000,HS3002121900 etc,
and its main trading partners are strenuus marketing s a s,global market alliance s.a.s..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on qalys pharma llc is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.